Fixed-dose combination antihypertensive medications

Ivor J Benjamin; Reinhold Kreutz; Michael H Olsen; Aletta E Schutte; Patricio Lopez-Jaramillo; Thomas R Frieden; Karen Sliwa; Daniel T Lackland; Michael Brainin

doi:10.1016/S0140-6736(19)31629-0

Fixed-dose combination antihypertensive medications

Ivor J Benjamin, Reinhold Kreutz, Michael H Olsen, Aletta E Schutte, Patricio Lopez-Jaramillo, Thomas R Frieden^*, Karen Sliwa, Daniel T Lackland, Michael Brainin

^*Corresponding author af dette arbejde

Medicinsk Afdeling

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning

Originalsprog	Engelsk
Sider (fra-til)	637-638
Antal sider	2
Tidsskrift	The Lancet
Vol/bind	394
Udgave nummer	10199
DOI	https://doi.org/10.1016/S0140-6736(19)31629-0
Status	Udgivet - 24 aug. 2019

Adgang til dokumentet

10.1016/S0140-6736(19)31629-0

Citationsformater

@article{ed9cab3e3a5f49f8aac7302e1b3a5d87,

title = "Fixed-dose combination antihypertensive medications",

keywords = "Antihypertensive Agents/economics, Drug Combinations, Global Health, Health Services Accessibility, Humans, Hypertension/drug therapy",

author = "Benjamin, {Ivor J} and Reinhold Kreutz and Olsen, {Michael H} and Schutte, {Aletta E} and Patricio Lopez-Jaramillo and Frieden, {Thomas R} and Karen Sliwa and Lackland, {Daniel T} and Michael Brainin",

year = "2019",

month = aug,

day = "24",

doi = "10.1016/S0140-6736(19)31629-0",

language = "English",

volume = "394",

pages = "637--638",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier B.V.",

number = "10199",

}

TY - JOUR

T1 - Fixed-dose combination antihypertensive medications

AU - Benjamin, Ivor J

AU - Kreutz, Reinhold

AU - Olsen, Michael H

AU - Schutte, Aletta E

AU - Lopez-Jaramillo, Patricio

AU - Frieden, Thomas R

AU - Sliwa, Karen

AU - Lackland, Daniel T

AU - Brainin, Michael

PY - 2019/8/24

Y1 - 2019/8/24

KW - Antihypertensive Agents/economics

KW - Drug Combinations

KW - Global Health

KW - Health Services Accessibility

KW - Humans

KW - Hypertension/drug therapy

U2 - 10.1016/S0140-6736(19)31629-0

DO - 10.1016/S0140-6736(19)31629-0

M3 - Comment/debate

C2 - 31320200

SN - 0140-6736

VL - 394

SP - 637

EP - 638

JO - The Lancet

JF - The Lancet

IS - 10199

ER -